- Home
- OCFC vs ORIC Comparison
OCFC vs ORIC Comparison
Compare OCFC & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OCFC | ORIC |
|---|---|---|
| Founded | 1902 | 2014 |
| Country | United States | United States |
| Employees | 1007 | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | OCFC | ORIC |
|---|---|---|
| Price | $17.74 | $11.12 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 13 |
| Target Price | ★ $21.33 | $20.00 |
| AVG Volume (30 Days) | 517.6K | ★ 1.4M |
| Earning Date | 04-23-2026 | 05-04-2026 |
| Dividend Yield | ★ 4.57% | N/A |
| EPS Growth | N/A | ★ 19.67 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $47.51 | N/A |
| Revenue Next Year | $21.97 | N/A |
| P/E Ratio | $16.71 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.29 | $3.90 |
| 52 Week High | $20.61 | $14.93 |
Technical Indicators
Market Signals| Indicator | OCFC | ORIC |
|---|---|---|
| Relative Strength Index (RSI) | 42.61 | 42.92 |
| Support Level | $17.28 | $9.46 |
| Resistance Level | $18.89 | $12.12 |
| Average True Range (ATR) | 0.45 | 0.78 |
| MACD | -0.01 | -0.26 |
| Stochastic Oscillator | 40.34 | 14.68 |
Price Performance
Historical ComparisonAbout OCFC OceanFirst Financial Corp.
OceanFirst Financial Corp is engaged in the banking sector of the United States. It conducts the business of attracting retail and business deposits and investing them in loans, consisting of single-family, owner-occupied residential mortgage loans, and commercial real estate loans. The company's sole segment deals with the delivery of loan and deposit products to customers. The bank's revenues are derived principally from interest on its loans, and to a lesser extent, interest on its investment and mortgage-backed securities. The rest of its income is dependent on bank card services and wealth management products and services.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.